RGRX
REGENERX BIOPHARMS INC by RegeneRx Biopharmaceuticals, Inc. (RGRX)
$00
About REGENERX BIOPHARMS INC by RegeneRx Biopharmaceuticals, Inc. (RGRX)
RegeneRx Biopharmaceuticals, Inc. engages in the development of a novel therapeutic peptide, Thymosin beta 4 for tissue and organ protection, repair, and regeneration. Its product pipeline includes RGN-259, RGN-352, and RGN-137. The company was founded by Allan L. Goldstein on May 13, 1982 and is headquartered in Rockville, MD.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.07
52 Week Low
$0.00
Market cap
300
Dividend yield
0.00%
Volume
--
Avg. volume
2,762
P/E ratio
--
REGENERX BIOPHARMS INC by RegeneRx Biopharmaceuticals, Inc. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.07
52 Week Low
$0.00
Market cap
300
Dividend yield
0.00%
Volume
--
Avg. volume
2,762
P/E ratio
--